Breaks Categories: Stock Spotlights

WednesdayAug 19, 2020 2:03 pm

PsychedelicNewsBreaks – Cybin Corp. Partners with IntelGenx to Develop Efficient Delivery Method for Pharmaceutical-Grade Psilocybin

Cybin Corp. recently announced its entry into a feasibility agreement with IntelGenx Corp., a leading drug-delivery company focused on the development and manufacturing of pharmaceutical delivery films (http://ibn.fm/TZeVy). Under the agreement, the two companies will collaborate to develop an orally dissolving, fast-acting film for the delivery of pharmaceutical-grade psilocybin. A recent article discussing this quotes Cybin’s Chief Medical Officer Dr. Jukka Karjalainen, who states, “We at Cybin are proud to be working with IntelGenx to develop a fast-acting psilocybin film. Compared to oral psilocybin capsules, which are subject to variable intestinal absorption and high first-pass metabolism in the liver, the systemic…

Continue Reading

TuesdayAug 04, 2020 12:39 pm

PsychedelicNewsBreaks – Pure Extracts Corp. to Drive Product Innovation with Leading-Edge Team, Technology

Pure Extracts, a private, plant-based extraction company with a new vertical in functional mushrooms, leverages a team of qualified experts and cutting-edge technology. The company’s distinction on a path toward opportunity was highlighted in a recent article, which reads, “Pure Extracts, on the other hand, is ideally positioned to enter the space as an experienced producer. With a team of qualified experts and cutting-edge extraction technology, the company is set up for long-term strategic distribution and product innovation. Located near Whistler, British Columbia, the company’s facility is built for EU-GMP certification, which allows for international sales and ensures the production…

Continue Reading

WednesdayJul 29, 2020 2:06 pm

PsychedelicNewsBreaks – Cybin Corp. to Deliver Psychedelic Medicines Targeting Conditions Failed by Big Pharma

Cybin Corp. appears set for opportunity as new data increasingly finds promise in psychedelic medicines. As big pharma has failed to bring groundbreaking drug innovations into the mental-health space, psilocybin — the main compound of pharmaceutical psychedelic products — stands out, having shown positive results for the treatment of anxiety, depression, addiction, and eating and other disorders. A recent article discussing the company’s positioning reads, “Cybin is potentially poised to be the first company to develop psilocybin-based medicine designed to target major depressive disorders. Currently involved in structuring a clinical study that will be conducted through an academic partner in…

Continue Reading

WednesdayJul 22, 2020 1:05 pm

PsychedelicNewsBreaks – Pure Extracts Corp. Leverages CO2 Technology in ‘Extraction Is Our Business’ Model

Pure Extracts, a private, plant-based extraction company with a new vertical in functional mushrooms, leverages CO2 technology, a process based on pressurized carbon dioxide that provides some of today’s cleanest, healthiest products. The company’s dedication to this process was highlighted in a recent article, which reads, “Pure Extract’s Vitalis C02 extraction technology allows for full-spectrum oil extraction, which results in the purest, highest-quality oil. In addition, the company, which notes that ‘extraction is our business,’ will soon have the capacity for more than 100,000 kg of biomass per year with a technique that has been tried and tested through its…

Continue Reading

WednesdayJul 22, 2020 12:52 pm

PsychedelicNewsBreaks – Cybin Corp. Advancing ‘Fungi-Derived’ Products Amid Mushrooming Interest in Psychedelics

Cybin Corp., a Canada-based, life-sciences company focused on the pharmaceutical development of psychedelic products as well as the functional mushroom market, looks to be in the right place at the right time. A mushrooming interest fuels this sector in an era where psychedelics, once a taboo substance, are being viewed in a powerful new light. A recent article discussing the company and its focus in this emerging space reads, “Cybin is committed to its mission of bringing ‘fungi-derived psychedelic and medicinal products into the world that may potentially drive the next discovery phase of life-changing medications to treat mental illness…

Continue Reading

TuesdayJul 14, 2020 1:39 pm

PsychedelicNewsBreaks – Pure Extracts Corp. Moves to Further Expand in the Functional Mushrooms Market

Pure Extracts, a private, plant-based extraction company, is focused on becoming a dominant extraction company in the functional mushrooms market, as well as a leader in the rapid development and commercialization of products in the emerging sector. A recent article discussing this reads, “Further establishing its power in the market, Pure Extracts has signed nondisclosure agreements to explore joint-development endeavors for product launches slated for potential Q4 delivery. The company also inked an advisory agreement with Dr. Alexander MacGregor, founder of Transpharm Canada Inc., the parent company of Toronto Institute of Pharmaceutical Technology, whose facility is a fully compliant Health…

Continue Reading

TuesdayJul 14, 2020 11:23 am

PsychedelicNewsBreaks – Why Cybin Corp. Is ‘One to Watch’

Cybin Corp. is Canada's premier mushroom life-sciences company focused on advancing psychedelic and nutraceutical-based products derived from fungi. A recent article discussing the company reads, “In particular, Cybin aims to further build upon and expand its intellectual property (‘IP’) portfolio, which is structured around unique psilocybin delivery mechanisms that target a number of different therapeutic indications. In addition, the company has dedicated itself toward furthering its research and IP within the fields of synthetic compounds, extraction methods, the isolation of chemical compounds, new drug formulations and protocol regimes.” To view the full article, visit http://ibn.fm/7l5CK About Cybin Cybin is a…

Continue Reading

FridayJun 19, 2020 2:12 pm

PsychedelicNewsBreaks – Why Pure Extracts Corp. Is ‘One to Watch’

Headquartered in Pemberton, British Columbia, Pure Extracts is a private, plant-based extraction company with a new vertical in functional mushrooms. A recent article discussing the company reads, “Current research is finding psychedelic benefits including anti-tumor, anti-viral, detoxification, immune function and mental wellness. As such, psychedelic compounds are now being examined by leading medical research and academic institutions for treatment of depression, PTSD, anxiety, bipolar disorder, obesity, narcolepsy, OCD, Alzheimer’s, ADHD, and drug and alcohol dependence. In 2020, the FDA granted breakthrough therapy status to psychedelics for treatment-resistant depression, with approvals anticipated in 2021. . . . Pure Extracts is well…

Continue Reading

ThursdayJun 04, 2020 2:14 pm

PsychedelicNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Names New CEO

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human-optimization sciences company with an emphasis on ketamine and psychedelic medicine, recently named Dr. Roger McIntyre as chief executive officer. An article discussing the company reads, “In his new role, Dr. Roger McIntyre brings impressive experience in the ketamine and psychedelic medicine space, a key focus area for Champignon. . . . ‘My overarching aim as chief executive officer is to establish Champignon as the apotheosis of integrated ketamine treatment delivery and the commercialization of our own IP psychedelic-based treatments,’ McIntyre stated in a news release. ‘The clinical infrastructure, complementary asset…

Continue Reading

FridayNov 22, 2019 3:24 pm

PsychedelicNewsBreaks – Hemptown USA Strategically Positioned to Become Largest North American Producer of CBD

Hemptown USA, a privately owned grower of full-spectrum, feminized hemp using premium-seed genetics, operates a farm operation with more than 500 acres dedicated to the cultivation of nonpsychoactive cannabigerol (“CBG”). The company’s recent harvest positioned it to be the largest producer of CBG in North America. An article discussing the company reads, “Hemptown USA has built CBD production from broad-spectrum hemp biomass in states such as Oregon, Kentucky and California, but has worked to increase its profile as hemp-friendly laws have been enacted — particularly last year’s farm bill that legalized commercial hemp cultivation nationwide following years of prohibition. .…

Continue Reading